Spermatogonia represent the initial stage of the male germ cell lineage and play a fundamental role in spermatogenesis—the process of sperm cell formation within the testes. These diploid cells reside in the seminiferous tubules and undergo mitotic divisions to replenish the pool of germ cells continuously. There are two types of spermatogonia: Type A, which are undifferentiated and maintain the stem cell population, and Type B, which undergo differentiation to eventually give rise to spermatozoa. Spermatogonia are regulated by hormonal signals, including follicle-stimulating hormone (FSH) and testosterone, which influence their proliferation and differentiation. The process of spermatogonial differentiation involves the transition from spermatogonium to primary spermatocyte, marking the initiation of meiosis. This complex and highly regulated sequence of events ensures the production of functional sperm with the correct chromosome number. Spermatogonia are integral to male fertility, and abnormalities in their function can lead to reproductive disorders. Studying spermatogonia is crucial for understanding the molecular mechanisms underlying spermatogenesis, as well as for developing strategies to address male infertility and improve assisted reproductive technologies. Advances in reproductive biology continue to unveil the intricate details of spermatogonial function, contributing to both clinical applications and broader insights into male reproductive health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy